These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34687305)

  • 1. Intravenous bisphosphonates do not improve knee pain or bone marrow lesions in people with knee osteoarthritis: a meta-analysis.
    Zhang X; Cai G; Jones G; Laslett LL
    Rheumatology (Oxford); 2022 May; 61(6):2235-2242. PubMed ID: 34687305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials.
    Vaysbrot EE; Osani MC; Musetti MC; McAlindon TE; Bannuru RR
    Osteoarthritis Cartilage; 2018 Feb; 26(2):154-164. PubMed ID: 29222056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Intravenous Zoledronic Acid on Tibiofemoral Cartilage Volume Among Patients With Knee Osteoarthritis With Bone Marrow Lesions: A Randomized Clinical Trial.
    Cai G; Aitken D; Laslett LL; Pelletier JP; Martel-Pelletier J; Hill C; March L; Wluka AE; Wang Y; Antony B; Blizzard L; Winzenberg T; Cicuttini F; Jones G
    JAMA; 2020 Apr; 323(15):1456-1466. PubMed ID: 32315057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.
    Laslett LL; Doré DA; Quinn SJ; Boon P; Ryan E; Winzenberg TM; Jones G
    Ann Rheum Dis; 2012 Aug; 71(8):1322-8. PubMed ID: 22355040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2.
    Aitken D; Laslett LL; Cai G; Hill C; March L; Wluka AE; Wang Y; Blizzard L; Cicuttini F; Jones G
    BMC Musculoskelet Disord; 2018 Jul; 19(1):217. PubMed ID: 30021646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between change in bone marrow lesion size and change in tibiofemoral cartilage volume and knee symptoms.
    Cai G; Aitken D; Laslett LL; Hill C; Wluka AE; March L; Cicuttini F; Pelletier JP; Martel-Pelletier J; Jones G
    Rheumatology (Oxford); 2021 Jun; 60(6):2791-2800. PubMed ID: 33253381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-articular corticosteroid for knee osteoarthritis.
    Jüni P; Hari R; Rutjes AW; Fischer R; Silletta MG; Reichenbach S; da Costa BR
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD005328. PubMed ID: 26490760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tramadol for osteoarthritis.
    Toupin April K; Bisaillon J; Welch V; Maxwell LJ; Jüni P; Rutjes AW; Husni ME; Vincent J; El Hindi T; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD005522. PubMed ID: 31132298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous neridronate in the treatment of acute painful knee osteoarthritis: a randomized controlled study.
    Varenna M; Zucchi F; Failoni S; Becciolini A; Berruto M
    Rheumatology (Oxford); 2015 Oct; 54(10):1826-32. PubMed ID: 25998450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoarthritis Bone Marrow Lesions.
    Walsh DA; Sofat N; Guermazi A; Hunter DJ
    Osteoarthritis Cartilage; 2023 Jan; 31(1):11-17. PubMed ID: 36191832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Pharmacological Treatments With Long-term Pain Control in Patients With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
    Gregori D; Giacovelli G; Minto C; Barbetta B; Gualtieri F; Azzolina D; Vaghi P; Rovati LC
    JAMA; 2018 Dec; 320(24):2564-2579. PubMed ID: 30575881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral wedge insoles as a conservative treatment for pain in patients with medial knee osteoarthritis: a meta-analysis.
    Parkes MJ; Maricar N; Lunt M; LaValley MP; Jones RK; Segal NA; Takahashi-Narita K; Felson DT
    JAMA; 2013 Aug; 310(7):722-30. PubMed ID: 23989797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid plus methylprednisolone
    Cai G; Laslett LL; Aitken D; Cicuttini F; March L; Hill C; Winzenberg T; Jones G
    Ther Adv Musculoskelet Dis; 2019; 11():1759720X19880054. PubMed ID: 31692649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow lesions predict increase in knee cartilage defects and loss of cartilage volume in middle-aged women without knee pain over 2 years.
    Wluka AE; Hanna F; Davies-Tuck M; Wang Y; Bell RJ; Davis SR; Adams J; Cicuttini FM
    Ann Rheum Dis; 2009 Jun; 68(6):850-5. PubMed ID: 18625617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise in knee osteoarthritis: do treatment outcomes relate to bone marrow lesions? A randomized trial.
    Beckwée D; Vaes P; Raeymaeckers S; Shahabpour M; Scheerlinck T; Bautmans I
    Disabil Rehabil; 2017 Sep; 39(18):1847-1855. PubMed ID: 27540824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial (ZoMARS).
    Seefried L; Genest F; Baumann J; Heidemeier A; Meffert R; Jakob F
    J Bone Miner Res; 2022 Mar; 37(3):420-427. PubMed ID: 34954857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of the association between hip bone marrow lesions, high cartilage signal, and hip and knee pain.
    Ahedi H; Aitken D; Blizzard L; Cicuttini F; Jones G
    Clin Rheumatol; 2014 Mar; 33(3):369-76. PubMed ID: 24196987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow lesions in knee osteoarthritis change in 6-12 weeks.
    Felson DT; Parkes MJ; Marjanovic EJ; Callaghan M; Gait A; Cootes T; Lunt M; Oldham J; Hutchinson CE
    Osteoarthritis Cartilage; 2012 Dec; 20(12):1514-8. PubMed ID: 22944524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.